Via: PR Newswire
Novel system to protect against stroke via direct carotid access and robust blood flow reversal initiates a new era in carotid revascularization
SUNNYVALE, Calif., Feb. 10, 2015 /PRNewswire/ -- Silk Road Medical, Inc., a pioneer in the development of transcarotid therapies for intra and extracranial vascular diseases, announces the company has received Food & Drug Administration (FDA) 510(k) clearance for its ENROUTE Transcarotid Neuroprotection System (NPS). The ENROUTE Transcarotid NPS is a first in class system used to directly access the common carotid artery and initiate high rate temporary blood flow reversal to protect the brain from stroke while performing carotid angioplasty and stenting (CAS).
Read More: http://www.prnewswire.com/news-releases/silk-road-medical-announces-fda-510k-clearance-of-the-enroute-transcarotid-neuroprotection-system-300033527.html
RSS Feed
